Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929174 · ClinicalTrials.gov registry record
Diffuse Myocardial Fibrosis in Fontan Patients
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 18
- Enrollment target
NCT01929174: Completed study, sponsored by Oregon Health and Science University.
NCT01929174 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01929174 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this protocol is to measure the relaxation of the heart in subjects with single ventricles who have undergone the surgical Fontan procedure. We will do this by measuring relaxation with MRI, echocardiography, and cardiac catheterization and compare to blood levels that measure heart scarring. We will also measure relaxation before and after boluses of intravenous (IV) fluids to see if the relaxation changes when there is more fluid in the heart. Measurements of heart relaxation will be obtained from the MRI, echocardiogram, and cardiac catheterization for each patient and compared to blood markers of heart scarring. We aim to compare all of these measurements to see if we can accurately identify heart scarring and, if present, how much it correlates with impaired heart relaxation.
Primary Outcome
All patients will have measurements of pressure and volume before and after IV fluid administration, as well as computation of their extracellular volume fraction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-08-01 |
| Est. Completion | 2019-03-01 |
What the finished NCT01929174 record still lists
NCT01929174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01929174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01929174 about?
NCT01929174 is a clinical study titled "Diffuse Myocardial Fibrosis in Fontan Patients". The purpose of this protocol is to measure the relaxation of the heart in subjects with single ventricles who have undergone the surgical Fontan procedure. We will do this by measuring relaxation with MRI, echocardiography, and cardiac catheterization and compare to blood levels that measure heart s...
What is the current status of trial NCT01929174?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2013-08-01. Estimated completion is 2019-03-01.
Who is sponsoring clinical trial NCT01929174?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI